F2RL1 and atopic eczema: The suppression of epidermal hyperplasia and reduction in serum TSLP levels by PCG treatment in the DNFB-induced atopic dermatitis mouse model (Figure 6) suggest that PCG can attenuate TSLP level by suppressing PAR2-mediated inflammatory signaling.